cetirizine and 9,10-dimethyl-1,2-benzanthracene

cetirizine has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frenkel, DD; Gorev, NP; Ionov, ID; Roslavtseva, LA	1

Other Studies

1 other study(ies) available for cetirizine and 9,10-dimethyl-1,2-benzanthracene

Article	Year
Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a)anthracene-treated rats. Anti-cancer drugs, 2018, Volume: 29, Issue:10 Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cetirizine; Drug Synergism; Female; Fibroblast Growth Factor 2; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Thalidomide; Vascular Endothelial Growth Factor A	2018

Article

Year

Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a)anthracene-treated rats.

Anti-cancer drugs, 2018, Volume: 29, Issue:10

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cetirizine; Drug Synergism; Female; Fibroblast Growth Factor 2; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Thalidomide; Vascular Endothelial Growth Factor A

2018